N o n - T u b e r c u l o u s  
M y c o b a c t e r i a
🤔  W h a t  a r e  N T M ?  D e f i n i t i o n  a n d  C l a s s i f i c a t i o n
NTM   Non- T uber culous M y cobact er ia  ar e a lar ge gr oup of m y cob act er ia that  
ar e  distinct fr om  the  M y cobact er ium tuber culosis comple x  M tb comple x,  
which includes  M. tuber culosis ,  M. bo vis ,  M. afr icanum ,  M. canet tii , and  
others). Ther e ar e o v er 150 species, with about 60 consider ed pot entiall y  
p athogenic t o humans.
Classif ic ation b y Gr o wt h R at e:
R apid Gr o w ers RGM  Colon y f or mation in less than 7 da ys. Examples  
include  M. abscessus ,  M. chelonae ,  M. f or tuitum ,  M. septicum , and  M.  
smegmatis .  M. abscessus  is p ar ticular l y not e w or th y f or it s association with  
c ystic fibr osis p atient s.
Slo w Gr o w ers:  Colon y f or mation in 740 da ys or longer . Examples  
include  M. a vium comple x  MA C, encomp assing  M. a vium ,  M. intr acellular e ,  
and  M. chimaer a ) and  M. x enopi .
Int er mediat e Gr o w ers:  Colon y f or mation bet w een 7 and 10 da ys. Examples  
include  M. mar inum  ( c auses skin lesions) and  M. gor donae .
Classif ic ation b y P at hogenicit y:  This classific ation considers the lik elihood of  
c ausing dise ase in immunocompet ent v ersus immunocompr omised host s.  
Some NTM ar e rar el y p athogenic, e v en in immunocompr omised individuals,  
while others ar e oppor tunistic p athogens that r equir e signific ant immune  
suppr ession t o c ause dise ase.  M. f or tuitum , f or e xample, is of t en consider ed a  
cont aminant, while MA C is a signific ant oppor tunistic p athogen in AIDS  
p atient s.
🌍  E p i d e m i o l o g y  a n d  T r a n s m i s s i o n  o f  N T M
Ubiquit ous Natur e:  NTM ar e f ound in v ar ious en vir onment al sour ces, including  
soil, wat er , and dust. This widespr e ad distr ibution contr ibut es t o their pot ential  
f or human inf ection.
T r ansmission R out es:
Non- T uber culous M y cob act er ia
1Inhalation:  The most common r out e, pr imar il y thr ough aer osoliz ed p ar ticles  
fr om cont aminat ed wat er sour ces ( e.g., sho w ers, hot tubs).
Ingestion:  Cont aminat ed wat er or f ood.
Dir ect Cont act:  Cut aneous inoculation thr ough w ounds or skin lesions.
Risk F act ors:
Immunocompr omised Host s:  Individuals with HIV , other  
immunodeficiencies, or those on immunosuppr essiv e medic ations ar e at  
signific antl y incr e ased r isk.
Under l ying Lung Dise ase:  Conditions lik e c ystic fibr osis CF, chr onic  
obstructiv e pulmonar y dise ase COPD, and br onchiect asis cr e at e a  
f a v orable en vir onment f or NTM colonization and inf ection.
Ot her F act ors:  Ad v anced age, cer t ain genetic pr edispositions ( e.g., CFTR  
mut ations), and specific anat omic al f e atur es ( e.g., pectus e x c a v atum) c an  
also incr e ase susceptibilit y .
P erson-t o-P erson T r ansmission:  While generall y consider ed rar e,  M.  
abscessus  has sho wn pot ential f or limit ed person-t o-person transmission,  
p ar ticular l y in CF p atient s. This highlight s the impor t ance of inf ection contr ol  
me asur es in he al thc ar e set tings.
🦠  N T M  a n d  A m e b a s :  A  U n i q u e  I n t e r a c t i o n
Some NTM species c an sur viv e and e v en r eplic at e within fr ee-living ameb as.  
This intracellular niche pr o vides pr ot ection fr om en vir onment al str essors and  
pot entiall y contr ibut es t o incr e ased antibiotic r esist ance. The pr esence of NTM  
within ameb as in wat er syst ems is a signific ant concer n, p ar ticular l y f or  
immunocompr omised individuals.
🫁  C l i n i c a l  P r e s e n t a t i o n s  o f  N T M  I n f e c t i o n s
Pulmonar y Dise ase:  The most common manif est ation, of t en pr esenting as a  
chr onic br onchopulmonar y dise ase. Sympt oms c an be subtle and nonspecific,  
including chr onic cough ( of t en pr oductiv e ), f atigue, w eight loss, and  
occ asionall y hemopt ysis ( coughing up blood). R adiologic al findings ma y  
include nodules, c a vities, and br onchiect asis.  M. a vium comple x  ( M. a vium ,  M.  
intr acellular e , and  M. chimaer a ) is a fr equent c ause of pulmonar y NTM  
dise ase.
Non- T uber culous M y cob act er ia
2Ex tr apulmonar y Dise ase:  NTM c an inf ect v ar ious e x trapulmonar y sit es,  
al though less fr equentl y than the lungs. These include:
L ymphadenitis:  Most commonl y af f ect s childr en, of t en pr esenting as  
p ainless, cold l ymph nodes.
Disseminat ed Dise ase:  Mor e common in se v er el y immunocompr omised  
individuals ( e.g., AIDS p atient s), of t en c aused b y MA C. Sympt oms c an be  
syst emic, including f e v er , w eight loss, and or gan in v ol v ement.
Skin and Sof t Tissue Inf ections:  F r equentl y c aused b y rapid-gr o wing  
m y cob act er ia RGM, of t en f ollo wing trauma or skin lesions.  M. mar inum  is  
a not able e xample, associat ed with e xposur e t o cont aminat ed wat er ( e.g.,  
aquar iums).
Bone and Joint Inf ections:  Usuall y r esul t fr om dir ect inoculation, of t en  
f ollo wing trauma or sur ger y .
Cat het er -R elat ed Inf ections:  R apid-gr o wing m y cob act er ia c an c ause  
inf ections associat ed with central v enous c athet ers CV Cs) and per it one al  
c athet ers.
🔬  D i a g n o s i s  o f  N T M  I n f e c t i o n s
Micr obiologic al Diagnosis:  The gold st andar d is the isolation of the same NTM  
species fr om at le ast t w o sep arat e sputum samples or fr om a br oncho al v eolar  
la v age BAL sample. Cul tur e is essential f or species identific ation and  
susceptibilit y t esting. PCR is incr e asingl y used but ma y not be as specific as  
cul tur e.
R adiologic al Diagnosis:  Chest X -ra ys and high-r esolution comput ed  
t omograph y HRCT sc ans ar e crucial f or e v aluating pulmonar y in v ol v ement.  
Findings ma y include nodules, c a vities, and br onchiect asis.
Amer ic an Thor acic Societ y A TS Diagnostic Cr it er ia:  The A TS pr o vides  
specific cr it er ia f or diagnosing pulmonar y NTM dise ase, emphasizing  
micr obiologic al e vidence and clinic al findings.
💊  T r e a t m e n t  o f  N T M  I n f e c t i o n s
T r e atment Pr inciples:  T r e atment is of t en pr olonged 12 2 4 months or longer),  
r equir es mul tiple antibiotics, and ma y ha v e signific ant side ef f ect s. The choice  
of antibiotics depends on the specific NTM species and it s susceptibilit y  
pr ofile.
Non- T uber culous M y cob act er ia
3Commonl y Used Antibiotics:  Macr olides (azithr om y cin, clar ithr om y cin),  
ethambut ol, and r if ampin or r if abutin ar e fr equentl y used in combination. F or  M.  
abscessus , tr e atment is p ar ticular l y challenging and ma y in v ol v e intra v enous  
therap y f ollo w ed b y pr olonged oral r egimens.
T r e atment Challenges:  NTM inf ections ar e not or iousl y dif ficul t t o tr e at due t o  
f act ors such as antibiotic r esist ance, slo w gr o wth rat es, and the f or mation of  
biofilms. T r e atment f ailur e and r elapse ar e common.
Inhaled Liposomal Amikacin:  A ne w er tr e atment option under de v elopment,  
of f er ing pot ential ad v ant ages in t er ms of drug deliv er y and r educed t o xicit y .
I m p o r t a n t  F a c t s  t o  M e m o r i z e
 NTM Def inition:   Non- T uber culous M y cobact er ia  ar e  
m y cob act er ia  e x cluding  the  M. tuber culosis  comple x. Ov er 150 species  
e xist, with 60 pot entiall y p athogenic.
 NTM Classif ic ation:  Classified b y gr o wth rat e (rapid, slo w , int er mediat e )  
and p athogenicit y ( oppor tunistic, rar el y p athogenic ).
 Ubiquit ous Natur e:  NTM ar e f ound in soil, wat er , and dust, le ading t o  
v ar ious transmission r out es (inhalation, ingestion, cont act).
 Risk F act ors:  Immunocompr omised st atus, under l ying lung dise ase, age,  
and genetic f act ors incr e ase susceptibilit y .  M. abscessus  has limit ed  
person-t o-person transmission pot ential, especiall y in CF p atient s.
 Ameb a Int er action:  NTM c an sur viv e and r eplic at e within ameb as,  
pot entiall y incr e asing antibiotic r esist ance.
 Pulmonar y Dise ase:  Most common pr esent ation; chr onic cough, f atigue,  
w eight loss, and sometimes hemopt ysis. R adiologic al findings include  
nodules, c a vities, and br onchiect asis.
 Ex tr apulmonar y Dise ase:  L ymphadenitis ( especiall y in childr en),  
disseminat ed dise ase (se v er e immunocompr omise ), skin/sof t tissue  
inf ections ( of t en RGM, bone/joint inf ections, and c athet er -r elat ed  
inf ections.
 Diagnosis:  Cul tur e fr om at le ast t w o sputum samples or BAL is the gold  
st andar d. HRCT sc ans ar e crucial f or imaging. A TS cr it er ia guide diagnosis.
 T r e atment:  Pr olonged 12 2 4 months), mul ti-drug r egimens; macr olides,  
ethambut ol, r if ampin/r if abutin ar e common.  M. abscessus  tr e atment is  
Non- T uber culous M y cob act er ia
4p ar ticular l y challenging.
 Inhaled Liposomal Amikacin:  Pr omising ne w tr e atment option.
 T r e atment Challenges:  Antibiotic r esist ance, slo w gr o wth, biofilm f or mation  
le ad t o high f ailur e and r elapse rat es.
 MA C M.  a vium comple x):  A signific ant oppor tunistic p athogen, especiall y  
in AIDS p atient s. Includes  M. a vium ,  M. intr acellular e , and  M. chimaer a .
 M.  abscessus:  A rapidl y gr o wing species, of t en associat ed with c ystic  
fibr osis and challenging t o tr e at.
 M.  mar inum:  Causes skin lesions, link ed t o e xposur e t o cont aminat ed  
wat er .
 M.  f or tuitum:  Of t en consider ed a cont aminant, rar el y p athogenic.
 A TS Diagnostic Cr it er ia:  Emphasiz e micr obiologic al e vidence ( cul tur e ) and  
clinic al findings.
 T r e atment Dur ation:  T ypic all y 12 2 4 months or longer , depending on the  
species and r esponse t o therap y .
 Drug R esist ance:  A signific ant concer n, necessit ating susceptibilit y t esting  
and t ailor ed antibiotic r egimens.
 Biof ilms:  Contr ibut e t o tr e atment dif ficul t y and incr e ased antibiotic  
r esist ance.
 Pr ognosis:  V ar iable, depending on the species, e x t ent of dise ase, and host  
immune st atus. T r e atment f ailur e and r elapse ar e common.
Non- T uber culous M y cob act er ia
5